OR WAIT null SECS
October 08, 2025
Article
The Q3 recap for endocrinology spotlights major FDA decisions, new guidelines for managing diabetes during pregnancy, and major clinical trial updates.
October 07, 2025
Catch up on FDA decisions, critical trial results, and expert perspectives on endocrinology.
August 08, 2025
Discover key advancements in endocrinology from July 2025, including FDA approvals and trial results.
July 21, 2025
Video
Presented at ENDO 2025, crinecerfont exhibited sustained androgen reduction when combined with glucocorticoids.
July 04, 2025
Explore key advancements in endocrinology from Q2 2025, including FDA approvals and groundbreaking diabetes research shaping future treatments.
May 29, 2025
The FDA approves hydrocortisone oral solution for pediatric adrenal insufficiency, enhancing dosing accuracy and ease for young patients and caregivers.
May 06, 2025
Our April 2025 month in review highlights significant advancements in endocrinology, including innovative therapies and FDA approvals that enhance diabetes management.
April 05, 2025
Our top 5 headlines featured key FDA moves in nephrology and ophthalmology, from new approvals to trial terminations and priority reviews.
March 13, 2025
Chronic hypoparathyroidism requires holistic management addressing more than just calcium normalization to achieve optimal patient outcomes.
August 12, 2024
Palopegteriparatide’s approval was based on positive data from the global Phase 2 PaTH Forward and Phase 3 PaTHway trials.
